Predicting Low Accrual in the National Cancer Institutes Cooperative Group Clinical Trials

Conclusions:
We identified multiple characteristics of NCTN-sponsored trials associated with low accrual, several of which have not been previously empirically described, and developed a prediction model that can provide a useful estimate of accrual risk based on these factors. Future work should assess the role of such prediction tools in trial design and prioritization decisions.

Source: JNCI - December 29, 2015 Category: Cancer & Oncology Authors: Bennette, C. S., Ramsey, S. D., McDermott, C. L., Carlson, J. J., Basu, A., Veenstra, D. L. Tags: Article Source Type: research